Singh AK - Search Results

1

Consensus on "Basal insulin in the management of Type 2 Diabetes: Which, When and How?".

Ghosal S, Sinha B, Majumder A, Das AK, Singh AK, Ghoshdastidar B, Maji D, Goyal G, Mukherjee JJ, Gangopadhyay KK, John M, Chatterjee S, Jaggi S, Ray S, Majumdar S, Sharma SK. Ghosal S, et al. Among authors: singh ak. J Assoc Physicians India. 2017 Jul;65(7):51-62. J Assoc Physicians India. 2017. PMID: 28792170

2

Clinical experience with insulin detemir, biphasic insulin aspart and insulin aspart in people with type 2 diabetes: Results from the Kolkata cohort of the A1chieve study.

Majumder A, Singh AK, Gangopadhyay KK, Sen R, Shetty R, Majumdar S. Majumder A, et al. Among authors: singh ak. Indian J Endocrinol Metab. 2013 Nov;17(Suppl 2):S584-7. doi: 10.4103/2230-8210.122144. Indian J Endocrinol Metab. 2013. PMID: 24404509 Free PMC article.

3

Advances in basal insulin therapy: lessons from current evidence.

Singh AK, Sinha B. Singh AK, et al. J Indian Med Assoc. 2013 Nov;111(11):735-6, 738-42. J Indian Med Assoc. 2013. PMID: 24968481 Review. No abstract available.

4

Modern basal insulin analogs: An incomplete story.

Singh AK, Gangopadhyay KK. Singh AK, et al. Indian J Endocrinol Metab. 2014 Nov;18(6):784-93. doi: 10.4103/2230-8210.140239. Indian J Endocrinol Metab. 2014. PMID: 25364672 Free PMC article. Review.

5

Review of Clinical Profile of IDegAsp.

Unnikrishnan AG, Singh AK, Modi KD, Saboo B, Garcha SC, Rao PV. Unnikrishnan AG, et al. Among authors: singh ak. J Assoc Physicians India. 2015 May;63(5 Suppl):15-20. J Assoc Physicians India. 2015. PMID: 26548030 Review.

6

Combination therapy of sodium-glucose co-transporter-2 inhibitors and dipeptidyl peptidase-4 inhibitors in type 2 diabetes: rationale and evidences.

Singh AK, Singh R. Singh AK, et al. Among authors: singh r. Expert Rev Clin Pharmacol. 2016;9(2):229-40. doi: 10.1586/17512433.2016.1123616. Epub 2015 Dec 25. Expert Rev Clin Pharmacol. 2016. PMID: 26589238 Review.

7

Sodium-glucose co-transporter-2 inhibitors as add-on therapy to insulin: rationale and evidences.

Singh AK, Singh R. Singh AK, et al. Among authors: singh r. Expert Rev Clin Pharmacol. 2016;9(3):409-18. doi: 10.1586/17512433.2016.1131121. Epub 2016 Jan 5. Expert Rev Clin Pharmacol. 2016. PMID: 26732230 Review.

8

Is gliclazide a sulfonylurea with difference? A review in 2016.

Singh AK, Singh R. Singh AK, et al. Among authors: singh r. Expert Rev Clin Pharmacol. 2016 Jun;9(6):839-51. doi: 10.1586/17512433.2016.1159512. Epub 2016 Mar 15. Expert Rev Clin Pharmacol. 2016. PMID: 26924475 Review.

9

Consensus on Initiation and Intensification of Premix Insulin in Type 2 Diabetes Management.

Mohan V, Kalra S, Kesavadev J, Singh AK, Kumar A, Unnikrishnan AG, Chawla R, Mukherjee JJ, Sahay RK, Kumar JS, Bhoraskar A, Asirvatham AJ, Panda JK, Zargar AH, Das AK. Mohan V, et al. Among authors: singh ak. J Assoc Physicians India. 2017 Apr;65(4):59-73. J Assoc Physicians India. 2017. PMID: 28527166

10

Evidence-Based Consensus on Positioning of SGLT2i in Type 2 Diabetes Mellitus in Indians.

Singh AK, Unnikrishnan AG, Zargar AH, Kumar A, Das AK, Saboo B, Sinha B, Gangopadhyay KK, Talwalkar PG, Ghosal S, Kalra S, Joshi S, Sharma SK, Sriram U, Mohan V. Singh AK, et al. Diabetes Ther. 2019 Apr;10(2):393-428. doi: 10.1007/s13300-019-0562-1. Epub 2019 Jan 31. Diabetes Ther. 2019. PMID: 30706366 Free PMC article. Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

5,946 results

Search Page

Filters